Detalhe da pesquisa
1.
PI3Kδ/γ inhibition promotes human CART cell epigenetic and metabolic reprogramming to enhance antitumor cytotoxicity.
Blood
; 139(4): 523-537, 2022 01 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35084470
2.
Venetoclax sensitivity in multiple myeloma is associated with B-cell gene expression.
Blood
; 137(26): 3604-3615, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33649772
3.
Daratumumab in multiple myeloma.
Cancer
; 125(14): 2364-2382, 2019 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30951198
4.
Clinical efficacy of daratumumab, pomalidomide, and dexamethasone in patients with relapsed or refractory myeloma: Utility of re-treatment with daratumumab among refractory patients.
Cancer
; 125(17): 2991-3000, 2019 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31090928
5.
Survival outcomes of patients with primary plasma cell leukemia (pPCL) treated with novel agents.
Cancer
; 125(3): 416-423, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30332496
6.
It takes T to tango: immunotherapy in MM.
Blood
; 139(9): 1259-1260, 2022 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35238890
7.
Bone marrow microenvironment-derived signals induce Mcl-1 dependence in multiple myeloma.
Blood
; 129(14): 1969-1979, 2017 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28151428
8.
ß adrenergic signaling regulates hematopoietic stem and progenitor cell commitment and therapy sensitivity in multiple myeloma.
Haematologica
; 107(9): 2226-2231, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35511673
9.
Statin-induced Mitochondrial Priming Sensitizes Multiple Myeloma Cells to BCL2 and MCL-1 Inhibitors.
Cancer Res Commun
; 3(12): 2497-2509, 2023 12 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37956312
10.
Regulation of antigen-specific T cell infiltration and spatial architecture in multiple myeloma and premalignancy.
J Clin Invest
; 133(15)2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37526080
11.
Genome-scale functional genomics identify genes preferentially essential for multiple myeloma cells compared to other neoplasias.
Nat Cancer
; 4(5): 754-773, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37237081
12.
Benefits of Autologous Stem Cell Transplantation for Elderly Myeloma Patients in the Last Quarter of Life.
Transplant Cell Ther
; 28(2): 75.e1-75.e7, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34626863
13.
Therapeutic implications of mitochondrial stress-induced proteasome inhibitor resistance in multiple myeloma.
Sci Adv
; 8(39): eabq5575, 2022 09 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36170375
14.
BCL2 Family Inhibitors in the Biology and Treatment of Multiple Myeloma.
Blood Lymphat Cancer
; 11: 11-24, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33737856
15.
Chromatin Accessibility Identifies Regulatory Elements Predictive of Gene Expression and Disease Outcome in Multiple Myeloma.
Clin Cancer Res
; 27(11): 3178-3189, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33731366
16.
Aberrant Extrafollicular B Cells, Immune Dysfunction, Myeloid Inflammation, and MyD88-Mutant Progenitors Precede Waldenstrom Macroglobulinemia.
Blood Cancer Discov
; 2(6): 600-615, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34778800
17.
Oncolytic herpes simplex virus infects myeloma cells in vitro and in vivo.
Mol Ther Oncolytics
; 20: 519-531, 2021 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33738338
18.
Long-Term Follow-Up Results of Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy and Risk-Adapted Maintenance Approach in Newly Diagnosed Multiple Myeloma.
J Clin Oncol
; 38(17): 1928-1937, 2020 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32298201
19.
Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myeloma.
Nat Commun
; 11(1): 1228, 2020 03 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32144272
20.
Cell of Origin and Genetic Alterations in the Pathogenesis of Multiple Myeloma.
Front Immunol
; 10: 1121, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31231360